Miguel Gómez Álvarez/LinkedIn
Jun 15, 2026, 13:51
Miguel Gómez Álvarez: Navigating the Complexities of Erythrocytosis and the Role of PIEZO1
Miguel Gómez Álvarez, Hematologist at Department of Hematology and Hemotherapy, Hospital Clínico San Carlos, Madrid, Spain, shared a post on X:
“Increasingly prevalent in our consultations… erythrocytosis, its complex differential diagnosis, PIEZO1, and the doubts about how to manage it at EHA 2026.
How do we categorize them and when to perform phlebotomies?”
Stay updated with Hemostasis Today.
-
Sep 29, 2026, 19:00Caitlin Raymond: Can Artificial Blood Solve Blood Supply Shortages?
-
Sep 29, 2026, 18:51Chaza Alaji: Dyslipidemia, Thrombosis and the DIC Diagnostic Trap
-
Sep 29, 2026, 17:31Rajnikant Patel: Bridging Ayurvedic Concepts and Modern Toxin-Mediated Disease
-
Sep 29, 2026, 17:13Nicholas Lang։ A Meaningful Case of Immune Thrombocytopenia
-
Sep 29, 2026, 16:55Ayatullah Gamal Wahab: When the CBC Lies
-
Sep 29, 2026, 16:35Jonathan Douxfils: Navigating the VTE Risk Continuum in Reproductive Medicine
-
Sep 29, 2026, 16:35Chaima Rajeh: Types of Anemia and Their Laboratory Features
-
Sep 29, 2026, 16:27Scott Isaacs: How GLP-1 RAs Target Systemic Inflammation to Drive Cardio, Autoimmune, and Gut Health
-
Sep 29, 2026, 16:21Yitshak Kreiss: From Treating Patients to Defining the Standard of Knowledge